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Revisiting the Anfinsen cage
R John Ellis
In the past five years, ideas about protein folding inside
cells have changed as a results of experiments with the
chaperonin family of molecular chaperones. The folding
of at least some proteins is no longer regarded as a
spontaneous energy-independent process, but as
involving transient interactions with chaperonin
ATPases that serve to increase the efficiency of correct
folding within the highly crowded intracellular
environment. This review discusses in an historical
context one model for how the chaperonins function.
This model suggests that proteins fold inside cells in
the same way as they do in pure dilute solution, but
that they do so inside macromolecular Anfinsen cages
that serve as sequestration devices to prevent and
reverse unproductive interactions.
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Introduction
At the first of the biennial European Science Foundation
conferences on molecular chaperones (held in September
1991), I introduced the term ‘Anfinsen cage’ to describe a
speculative model for how the chaperonins assist protein
refolding in vitro, based on the scanty evidence available
at that time. Some of the research findings published
since 1991 can be interpreted in terms of the Anfinsen
cage model, and the aim of this review is to discuss the
current status of the model in the light of these findings.
The chaperonins are one family of sequence-related mole-
cular chaperones found in chloroplasts, mitochondria, and
eubacteria such as Escherichia coli [1]. This group of pro-
teins are called the GroE chaperonins1 to distinguish them
from the more distantly related group of TCP-1 chaper-
onins2 found subsequently in the archaebacteria and the
eukaryotic cytosol [2]. The discovery of the GroE chaper-
onins triggered a continuing wave of novel research on the
mechanisms by which they increase the yield of correctly
refolded proteins in a variety of in vitro and in organello
systems (reviewed in [3–5]). This research has modified
the long-standing view that polypeptides newly synthe-
sized inside cells fold spontaneously to their functional
conformations in an energy-independent fashion. This
view is based on the pioneer experiments of Anfinsen,
who showed that some pure denatured proteins will refold
spontaneously in vitro, in the absence of either other
macromolecules or an energy source [6]. The modified
view proposes that in the highly crowded environment
found inside cells, some polypeptides are helped to fold
correctly by pre-existing proteins acting as molecular
chaperones, some of which hydrolyze ATP. The need for
molecular chaperones is suggested to arise because the
high concentrations of transiently interactive surfaces
found inside cells generate the risk that incorrectly folded
non-functional structures may form, the magnitude of this
risk varying for different polypeptides [7–8].
Two families of molecular chaperone have been recog-
nized with respect to protein folding. The
DnaK/DnaJ/GrpE (or hsp70) group members3 bind to
growing polypeptide chains as they are still being synthe-
sized by ribosomes and act to prevent premature folding.
The chaperonin family members assist correct folding at a
later stage, when complete chains have either left the
ribosome or have been transported into mitochondria and
chloroplasts from the cytosol [4,9]. The basic function of
the chaperonins is to reduce the probability of formation
of incorrectly folded protein structures.
The first report of the ability of the GroE chaperonins to
improve the yield of proteins correctly refolding in vitro
after removal or dilution of the denaturant was provided
by the DuPont group in 1989 [10]. In the same year, two
other publications reported that the chaperonin homo-
logue inside mitochondria is required for the correct
folding of several proteins imported into yeast mitochon-
dria in vivo [11] and isolated Neurospora mitochondria in
organello [12]. The work reported by Ostermann et al. [12]
is of special importance for two reasons. Firstly, it con-
cerns the folding of a monomeric protein, dihydrofolate
reductase (DHFR), whereas the other studies used
oligomeric proteins (where it was not definitively estab-
lished that the chaperonin was assisting folding and/or
oligomerization); confirmation that the GroE chaperonins
can assist the in vitro refolding of both denatured DHFR
and another denatured monomeric protein, rhodanese,
appeared in 1991 [13]. Secondly, the DHFR protein
refolds spontaneously in vitro with high speed and effi-
1The GroEL and GroES proteins were identified in the 1970s as
bacterial proteins required for the replication of bacteriophages such
as  in E. coli. ‘Gro’ refers to phage growth and ‘E’ to the observation
that the phage  growth defect is overcome when the phage carries a
mutation in the phage head gene E. See [5] for further discussion.
2The TCP-1 protein, t-complex polypeptide 1, was identified originally
in 1979 as a product of the T locus in mice. See [5] for further
discussion. 3DnaK, DnaJ and GrpE are bacterial proteins required for
the initiation of replication of phage  DNA in E. coli; DnaK is the heat-
shock protein 70 homologue in E. coli.
ciency, but nevertheless interacts with the mitochondrial
chaperonin after import by isolated mitochondria. This
finding was the first to indicate that the fact that a protein
refolds spontaneously in vitro to give the correct product
does not necessarily mean that it folds spontaneously in
vivo. Binding to GroEL of two proteins newly synthesized
in crude extracts of E. coli had been shown in 1988 [14],
and this binding in the case of one protein was found to
enhance its ability to be subsequently transported across
bacterial membranes, suggesting that binding to GroEL
stabilizes a folding intermediate that can be readily
unfolded for translocation.
These and many subsequent reports have generated
several different proposed mechanisms for how the chap-
eronins achieve their remarkable feat of helping proteins
to refold correctly. In this review, I describe the initial for-
mulation of one of these, the Anfinsen cage model, and
then argue that some of the more recent research findings
support my view [15] that this type of model provides the
best current description of how the GroE chaperonins
function in vitro, especially under conditions most closely
related to those found within the intracellular environ-
ment. There is also evidence that this type of model
applies to the action of the TCP-1 chaperonin from the
eukaryotic cytosol [16]. A fuller account that discusses the
Anfinsen cage model in the context of protein folding
under intracellular conditions is available [3], and the
structure, function and evolution of both the GroE and
TCP-1 chaperonins are extensively discussed in a book to
be published shortly [5]. 
Evidence available in 1991
The two chaperonins from E. coli are by far the best
studied. It was known in 1991 that the larger chaperonin,
GroEL, consists of two stacked rings, each made of seven
identical chaperonin 60 subunits and enclosing a central
cavity [17–19]. Each subunit contains 547 aminoacyl
residues (Mr 57 144) and exhibits a Mg2+-dependent
ATPase activity [1,17]. The homologous proteins inside
chloroplasts [1,20,21] and mitochondria [22,23] have very
similar structures, also occurring as 14-mers of chaperonin
60 subunits. The GroE chaperonin subunits from eubacte-
ria, mitochondria and chloroplasts show about 42–50%
aminoacyl identity to one another, with a further 18–20%
conservative substitutions, and it is striking that the
regions of similarity are distributed fairly evenly through-
out the primary structure. The smaller chaperonin from E.
coli, GroES, consists of a single ring of seven identical
chaperonin 10 subunits, each of Mr 10 368 [1,24]. 
In the presence of either Mg⋅ATP or Mg⋅ADP, one GroES
7-mer binds to one end of one GroEL 14-mer to form an
asymmetric binary complex [19,24]. In this complex, the
GroES sits over the cavity of one ring of GroEL, leaving
the cavity at the other end open to the medium. This
binding of GroES also appears to cause conformational
changes in GroEL, as judged by changes in the appear-
ance of negatively stained images under the electron
microscope [19]. The issue is how to account for the
ability of this complex to assist the refolding of denatured
proteins in what I call ‘neo-Anfinsen’ experiments, the
first example of which was published by Goloubinoff et al.
[10].
In neo-Anfinsen experiments, a pure protein is first dena-
tured by incubation with high concentrations of either
urea or guanidine hydrochloride and is then diluted
50–200-fold into a renaturing buffer containing GroEL at
an oligomeric molar concentration at least equal to the
final concentration of denatured protein subunits. GroES,
ATP, Mg2+ and K+ ions may also be present in this buffer
or added later. Goloubinoff et al. [10] used the dimeric
bacterial enzyme ribulose bisphosphate carboxylase oxy-
genase (rubisco) and found that this enzyme fails to refold
correctly if diluted into the renaturing buffer at 25°C in
the absence of chaperonins. Less than 2% of the original
rubisco activity appears after incubation for 2 h and less
than 10% after incubation for 24 h; at high protein concen-
trations, insoluble aggregates form in a few minutes. Thus,
the principle of protein self-assembly fails for this protein
under these conditions. If the temperature of incubation is
reduced to below 25°C, however, the recovery of active
enzyme increases, until all the activity is recovered at
10°C and below on incubation for 24 h [25]. Thus, all the
information for this protein to fold correctly is present in
its primary structure, but this information cannot be uti-
lized with sufficient speed and accuracy under physiologi-
cal conditions to account for the rate of formation of active
enzyme by bacterial cells growing rapidly at 25°C. The
problem appears to be that the folding rubisco chains
aggregate with one another rather than folding separately,
and it is the suggested function of the chaperonins to over-
come this problem. What is the evidence that they can do
this?
If the refolding buffer at 25°C contains a molar excess of
GroEL oligomers to rubisco subunits when the latter are
diluted, a stable binary complex forms in which one
rubisco subunit is non-covalently bound to one GroEL
oligomer. No other cellular factors are required for this
complex to form, and it is stable at 25°C for at least 16 h.
This complex resembles the one reported earlier as an
intermediate in the assembly of the plant rubisco in iso-
lated chloroplasts [20]. Addition of Mg⋅ATP, K+ ions and
GroES then results in the discharge of the complex and
the recovery of up to 80% of the original active rubisco
dimers in 30 min [10]. The formation of the binary
complex between GroEL and some refolding intermedi-
ate of rubisco is an obligatory step in the chaperonin-
dependent refolding pathway. This rubisco refolding
intermediate is also observed in the spontaneous refolding
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of rubisco at 15°C and can be trapped by chaperonin 60 in
a stable binary complex, thus inhibiting the spontaneous
refolding process until both GroES and ATP are added
[25]. A similar observation has been made for the refolding
of the precursor of -lactamase, which also forms a stable
1:1 complex with GroEL, although in this case the rever-
sal of the inhibition of refolding requires Mg⋅ATP only
(i.e. not GroES as well) [26].
The pioneer observations of Goloubinoff et al. [10] were
soon extended to citrate synthase from pig heart mito-
chondria, a protein also very prone to self-aggregation after
dilution from guanidine hydrochloride; correct refolding of
this protein also requires the two chaperonins and
Mg⋅ATP [27]. A more detailed report from the Hartl labo-
ratory [13] showed that DHFR and rhodanese are bound
to GroEL in a compact state resembling a ‘molten
globule’ or compact intermediate. The significance of this
discovery is that molten globules are prone to aggregation
because they expose some hydrophobic regions on their
surface, so their binding to GroEL rationalizes the ability
of GroEL to suppress aggregation. In the case of rho-
danese, the important observation was made that the addi-
tion of casein to the renaturing buffer does not reduce the
refolding of rhodanese triggered by adding Mg⋅ATP and
GroES to the binary complex. Casein has some affinity for
GroEL even when undenatured and so competes with
denatured rhodanese for GroEL binding. Measurements
of the amount of ATP required for the refolding of rho-
danese by the two chaperonins give a value of about 130
moles of ATP per mole of rhodanese [13]. The hydrolysis
of ATP by the GroEL–GroES complex had been shown
to be cooperative [28], so that several rounds of hydrolysis
are required to refold one molecule of rhodanese. In the
absence of both casein and GroES, ATP hydrolysis causes
the release of bound rhodanese into the medium, where it
aggregates, but when casein is present this aggregation is
strongly enhanced. Thus, GroES is required for rhodanese
to be released in a form that is either competent for refold-
ing correctly or at least has a much reduced tendency to
aggregate in the presence of casein. This conclusion
implies that structural rearrangements that produce this
form take place when the rhodanese is associated with the
GroEL–GroES complex, and not when the rhodanese is
released into the medium. This latter implication had a
strong influence on the formulation of the Anfinsen cage
model.
Initial formulation of the Anfinsen cage model
In 1991, in the light of the above findings, I proposed a
model (see Fig. 1) with the following basic postulates:
1. Chaperonin 60 is essentially a cage with multiple internal
binding sites for many regions of one unfolded polypeptide
chain, which binds in a cooperative manner to form a stable
binary complex. As first pointed out by Laminet et al. [26]
and discussed by Creighton [29], the 1:1 stoichiometry of
polypeptide binding suggests that the polypeptide binds in
the centre of the ring-shaped oligomer. It was proposed
that the binding is at least partially inside the cavity to
account for the observation that GroEL prevents polypep-
tide aggregation. Multiple binding sites were suggested to
account for both the uniform sequence similarity found in
chaperonin 60 subunits from different sources and the need
to tether the polypeptide chains at more than a few points
to prevent misfolding. 
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Figure 1
Initial formulation of the Anfinsen cage model
as presented in 1991 at the first of the
biennial European Science Foundation
conferences on molecular chaperones. See
text for discussion. The black spheres coating
the in vivo nascent chains represent the idea
that newly synthesized polypeptide chains are
bound to heat shock 70 proteins before
transfer to chaperonin 60 [45].
The Anfinsen cage model
Chaperonin 60 Binary complex
In vivo
In vitro
Nascent chains
Expansion
of cage
+ Chaperonin 10
Folded monomer
+ Mg.ATP
Co-operative
release inside
the cage and
Anfinsen folding
Binding at
multiple sites
inside the cage
2. Binding inside the cage prevents incorrect interactions
between regions of the bound unfolded polypeptide and
with unfolded polypeptides outside the cage. This inter-
nal binding provides the essential molecular chaperone
function of the chaperonin 60 oligomer, as it sequesters
molecules that may otherwise interact in an unproductive
manner.
3. Binding and hydrolysis of Mg⋅ATP causes binding to be
reversed in a cooperative manner so that the polypeptide
released into the cavity can fold correctly in true Anfinsen
fashion. This reversal is triggered by conformational
changes that permit the binding of chaperonin 10 and may
also enlarge the cage. Cooperative (rather than stepwise or
random) release of the chain was suggested, because in
this hypothesis all regions of the primary structure are
available more or less simultaneously, so that there are no
constraints due to unavailability of certain regions on the
interactions possible within the chain. It is for this reason
that the term ‘Anfinsen cage’ was coined, as it encapsu-
lates the idea that in this model proteins fold exactly as
they do in a classic Anfinsen experiment, but inside a pro-
tective container.
4. Binding of a chaperonin 10 oligomer to one face of a
chaperonin 60 oligomer triggers an expansion of the latter
that is necessary to ensure the release of large and/or
tightly bound polypeptides. This suggestion was made to
account for the requirement of chaperonin 10 for the
release of rubisco but not DHFR, and to offer a solution to
what I felt was a serious doubt about the model—is the
cage big enough? The cage must contain water if the
polypeptide is to fold in an aqueous environment, and of
course some polypeptides are considerably larger than
rubisco subunits. Estimates made from published nega-
tively stained images of GroEL suggested that the cage
might have dimensions of 130 Å × 110 Å × 40 Å, and the
dimensions of folded bacterial rubisco subunit are about
70 Å × 60 Å × 30 Å (molten globule forms will be slightly
larger). How accurately the values for GroEL reflect those
found under physiological conditions was unknown.
5. The folded monomer leaves the expanded cage and
another unfolded polypeptide enters the cage. 
Problems with the model
With hindsight, the major problem with this type of model
is that it fails to accommodate the fact that a polypeptide
released into an aqueous cavity is free to diffuse out of
that cavity at a rate much faster than the spontaneous rate
of refolding. Thus, a compact intermediate 50 kDa in size
takes only about 0.5 ms to diffuse 100 nm, which is the
average distance between GroEL molecules in both the
typical neo-Anfinsen experiment and inside living E. coli
cells [3]. This is a much shorter time than it takes the
average protein to refold, and during this time the folding
intermediates may aggregate with one another at a rate
dependent on their concentration. This problem is greatly
enhanced in vivo, where their thermodynamic activity is
greatly increased by macromolecular crowding and their
diffusion rates are simultaneously decreased [3,30]. It is
for this reason that I regard as artefacts of the in vitro con-
ditions used reports that compact intermediates can jump
between several GroEL molecules and fold in free solu-
tion while in transit between them. Unpublished data by
J Martin, M Mayhew and F-U Hartl indicate that jumping
of rhodanese between GroEL molecules is suppressed by
the addition of synthetic crowding agents to mimic in vivo
conditions (see [3] for discussion of this point). Detailed
kinetic studies of the refolding of small proteins such as
barnase [31] and chymotrypsin inhibitor 2 [32] in the pres-
ence of GroEL are also inconsistent with folding occurring
in free solution.
The diffusion problem could be overcome if there were a
means of retaining the folding intermediate inside the
cavity for a sufficient period of time. But in 1991, the
cavity was thought to extend right through the GroEL
oligomer and GroES binding is to one end only, so it was
not clear how the folding intermediate could be retained.
It is encouraging that a number of papers have appeared
more recently using biochemical, electron microscopic and
X-ray diffraction techniques that offer possible solutions
to this and other problems. Space restrictions do not allow
mention of all the relevant papers.
Some recent evidence in favour of the Anfinsen cage
model
Elegant studies from the laboratory of Helen Saibil have
provided three-dimensional images of chaperonin 60
oligomers by both negative stain [33] and cryo-electron
microscopy [34]. These images suggest that there may be
a cavity at each end of the oligomer with little or no
channel between them, but that at any one time only one
of these is occupied by a compact intermediate, presum-
ably due to a negative cooperativity for binding between
the rings. The compact intermediate is bound between
the outer domains of the subunits, a conclusion con-
firmed by the genetic identification of hydrophobic
residues in this domain that are required for polypeptide
binding [35]. The crystal structure of a double mutant
form of GroEL has been determined [36] and shows the
existence of two other domains in each subunit. The
equatorial domain contains the nucleotide-binding site
[35], and the intermediate domain connects it to the
apical domain. Both the N and C termini project into the
central channel from the equatorial domain, but unfortu-
nately these regions are disordered in the crystal, so it is
not clear whether the two cavities are connected or not.
The most interesting observation comes from cryo-elec-
tron microscopy: addition of GroES and nucleotide to
GroEL causes a hinge opening of the outer domain that
R12 Folding & Design Vol 1 No 1
creates a large cavity (65 Å × 80 Å) under the GroES
oligomer [34]. It is tempting to think that this is the
cavity in which the released protein is retained long
enough to internalize its hydrophobic regions, i.e. until
the danger of aggregation is passed. Experiments with
temperature-sensitive GroEL mutants of E. coli suggest
that aggregation is a real problem in vivo if GroEL func-
tion is suppressed [37]. Is there any biochemical evi-
dence that links protein folding with the cavity under the
GroES?
A number of different biochemical techniques were used
by Martin et al. [38] to define the relation between GroEL
and GroES in the folding of citrate synthase and rho-
danese. This paper argues that the role of GroES is vital to
our understanding of the mechanism of chaperonin action,
because in the case of proteins such as rhodanese, whose
spontaneous folding is prone to aggregation, GroEL alone
is insufficient to prevent aggregation when the rhodanese
bound to it is released by addition of Mg⋅ATP. The obser-
vations made in this work, in combination with later
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Figure 2
Current model for the refolding of
dihydrofolate reductase by GroEL and GroES.
Symbols: ADP, the seven subunits in a GroEL
ring that are bound to GroES in a high-affinity
ADP-bound state; ATP, the seven subunits in
a GroEL ring in the ATP-bound state; U,
unfolded polypeptide as a compact folding
intermediate (open sphere). Steps: 1,
polypeptide binding facilitates dissociation of
tightly bound ADP and GroES; 2, polypeptide
is bound transiently to nucleotide-free ring; 3,
ATP binds and GroES reassociates with the
polypeptide-containing ring of GroEL; DHFR
protein is released into the GroEL cavity
where it folds to the native state (hatched
sphere); GroES association with the free
GroEL ring is not shown; the seven subunits
of GroEL that interact with GroES hydrolyze
ATP—this step may be required for the
refolding of some polypeptides but is not
required for DHFR; 4, GroES is bound stably
to the GroEL subunits in the ADP-bound
state, enclosing the folded DHFR in the
GroEL cavity; 5, ATP binding and hydrolysis in
the opposite GroEL ring leads to GroES
dissociation and folded DHFR emerges into
the medium; 6, incompletely folded protein is
recaptured before it leaves GroEL and may
undergo partial unfolding to allow structural
rearrangement in preparation for another
folding cycle in the GroEL cavity. This model
is based on data from [38] and unpublished
data from M Mayhew, ACR da Silva, J Martin,
H Erdjument-Bromage, P Tempst and F-
U Hartl. Reprinted from [3] with kind
permission.
U
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2
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ADP ADP
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unpublished data using DHFR, produced the model of
chaperonin action shown in Figure 2 and discussed in
[15,38].
The complex of GroEL and GroES induced by the pres-
ence of Mg⋅ADP is the most stable of the various com-
plexes possible, so is likely to be the predominant form in
vivo. The key observation is that binding of a compact
intermediate to the ring of this complex not bound to
GroES triggers the release of GroES and ADP from the
other ring, i.e. the polypeptide competes with GroES for
binding to GroEL (see Fig. 2). Binding of Mg⋅ATP then
results in the rebinding of GroES with roughly equal prob-
ability to either end of the GroEL. GroES cannot bind to
both rings at the same time under the conditions used, as
ATP binding is necessary for GroES binding and itself
exhibits negative cooperativity [39]. Thus, some of the
bound polypeptide is now in a cavity capped by GroES.
Unpublished data by M Mayhew, ACR da Silva, J Martin,
H Erdjument-Bromage, P Tempst & F-U Hartl show that
addition of GroES alone in the absence of ATP hydrolysis
is sufficient to release bound DHFR into the cavity,
where it can fold all the way to the native state while
remaining within the cavity; this interpretation is consis-
tent with independent work reporting overlap between
the sites on GroEL that bind polypeptide and those that
bind GroES [35]. The discovery that GroES binding, and
not ATP hydrolysis, releases the bound polypeptide is
another respect in which the initial formulation is incor-
rect, at least for DHFR. Multiple rounds of release and
rebinding within the cavity may be necessary for some
proteins until all their hydrophobic regions are internal-
ized. The more folded protein diffuses away from the
cavity when the GroES unbinds on hydrolysis of the ATP.
Thus, it is the ATP hydrolysis time that determines how
long the cavity remains capped by GroES. It is possible to
distinguish between the two rings of the GroEL–GroES
complex, because the binding of GroES to one ring pro-
tects the subunits of that ring against removal of their 16
C-terminal residues by proteinase K, whereas the subunits
in the ring not bound to GroES have these residues
removed [38]. The ATP hydrolysis that releases GroES is
catalyzed by the GroEL ring that is not bound to GroES,
emphasizing the importance of cooperative interactions
between the rings in the operation of the Anfinsen cage
(see Fig. 2).
The observation that GroEL releases bound compact
intermediates in non-native form into the medium under
certain conditions, e.g. in the absence of GroES, has led to
the proposal that one function of the chaperonin is to bind
intermediates in such a way as to cause partial unfolding,
i.e. breakage of some non-covalent bonds [40–42]. The
notion that binding to GroEL may cause some partial
unfolding is not inconsistent with the view that binding
and rebinding occurs in the cavity, despite a claim to the
contrary [42]. Compact intermediates of mitochondrial
malate dehydrogenase become trapped in a kinetically
stable form when incubated at 36°C; these intermediates
do not aggregate and will refold correctly if GroEL,
GroES and Mg⋅ATP are added [43]. This example sug-
gests that some proteins require the chaperonins to fold
correctly, not to avoid a potential aggregation problem, but
to reverse stable misfolded states. The suggestion that one
feature of GroEL is the ability to allow the reorganization
of kinetically trapped species can be linked to the discov-
ery that the spontaneous refolding of lysozyme involves
the reorganization of kinetically distinct populations
emerging from the initial compact intermediate [44].
Conclusions
Recent findings support the conclusion that the chaper-
onins increase the yield of correctly folded polypeptide
chains by a sequestration mechanism that both decreases
the probability of aggregation and allows polypeptides
kinetically trapped in incorrect conformations to make
fresh attempts to fold correctly inside the Anfinsen cage
provided by the chaperonin oligomeric structure. Many
problems remain, and it is unlikely that the refolding of all
the different polypeptides interacting with chaperonins
proceeds by exactly the same route. However, this conclu-
sion should please protein chemists who have extended
with sophisticated methods the earlier studies of Anfinsen
on the refolding of pure denatured proteins, as it implies
that proteins fold inside cells in the same manner as they
refold inside test tubes. Intuitively, this seems a plausible
conclusion; Chris Dobson has pointed out to me that since
protein refolding is not random, but follows certain path-
ways, it is unlikely that a very different mechanism oper-
ates inside cells. 
And what about the ‘cage’? One of the unexpected
bonuses of the electron microscopy and X-ray crystal work
is the discovery that openings occur in the side of the
GroEL subunits that may allow nucleotides access to the
equatorial domain [33,36]. Chaperonin 60 really is a cage!
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